Fulvestrant as a reference antiestrogen and estrogen receptor (ER) degrader in preclinical studies: treatment dosage, efficacy, and implications on development of new ER-targeting agents.

ABSTRACT:

SUBMITTER: Wang G 

PROVIDER: S-EPMC7508469 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature